Don’t miss – Page 155 – Endpoints News

SIGN UP

GSK injects $293M cash into CureVac, forging a deal to develop new mRNA vaccines and antibodies

3 years ago

A Jennifer Doudna-led team finds a new CRISPR enzyme in the giant viruses of a California mud bog

3 years ago

Covid-19 roundup: EU looks to pre-order vaccines from Moderna, Sanofi, J&J, BioNTech, CureVac — report

3 years ago

Suggested by Bloomberg, blessed by analysts, could an M&A match with a certain MS player be far off for blockbuster-hungry Sanofi?

3 years ago

Gilead's ex-R&D chief Bischofberger heads back to the biotech giant to pick up a pair of late-stage drugs that had been put aside

3 years ago

Covid-19 roundup: Russia hackers target US, UK vaccine and drug researchers; Fauci fires back at White House campaign to undermine him

3 years ago

A neurosurgeon spent the past 30 years developing a neoantigen tumor vaccine. Now he has $112M for a pivotal test

3 years ago

‘Planning to vaccinate everyone in the US,’ Moderna outlines efforts to supply their Covid-19 vaccine as manufacturing ramps up ahead of PhIII

3 years ago

Covid-19 roundup: Vaccine by end of 2020? Ken Frazier warns hype doing 'grave disservice'

3 years ago

NIAID and Moderna spell out a 'robust' immune response in PhI coronavirus vaccine test — but big questions remain to be answered

3 years ago

Why pay $4B for a steady diet of disappointment? Porges turns thumbs down on Alexion’s M&A strategy, offers some pointers

3 years ago

Covid-19 roundup: After Trump attack, doctors, researchers flock to defend Fauci; Philip Morris-backed Medicago begins dosing tobacco-based vaccine

3 years ago

Diagnostic champ Roche buys its way into the RET title fight with Eli Lilly, paying $775M in cash to Blueprint

3 years ago

Engineering an on/off switch for CAR-T out of yeast and Jurassic Park

3 years ago

White House tries to discredit Anthony Fauci — could he be on his way out?

3 years ago

Covid-19 roundup: CanSino eyes more overseas PhIII sites as Canada trial reportedly stalls; Indian drugmaker surges on 30-person data

3 years ago

China's BeiGene now has $5B+ cash in its coffers. How's the Amgen-partnered biotech going to spend it?

3 years ago

Covid-19 roundup: BioNTech going head-to-head with Moderna as PhIII mRNA launch looms; Trial on Shinzo Abe’s once-favorite antiviral is inconclusive

3 years ago

Nick Galakatos and the Blackstone team now have a record $4.6B to invest in biopharma, with a big focus on pushing companies over the top

3 years ago

After psilocybin and ketamine, a new biotech comes along developing a drug Scott Gottlieb fought

3 years ago

Merck expands scope of Zymeworks antibody alliance, adding close to $900M in milestones

3 years ago

Stanford star oncology scientist Ed Engleman helped create the immunotherapy field. Now he wants to shake up neurodegeneration R&D

3 years ago

Another biotech IPO set-up? Multinational biotech leaps from round to round, scooping up cash at a blistering pace

3 years ago

Covid-19 roundup: CDC debating who should get first available vaccines; EU in Gilead talks after US gobbled first remdesivir doses

3 years ago

First page Previous page 152 153 154155156 157 158 Next page Last page